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Abstract
Background & aim : The number of accumulated cases of duodenal adenoma/adenocarcinoma is insuffi-
cient to allow the endoscopic characteristics, invasion depth diagnosis, and standard therapeutic method to be 
established. Here, we report clinicopathological features and endoscopic treatment outcomes in primary non-
ampullary duodenal tumor cases at our hospital.
Methods : The clinicopathological features of the patients and tumors, including age, sex, tumor size, loca-
tion, macroscopic type, and tumor color (red or not) were evaluated with respect to the histopathological diagnosis.  
The short-term outcomes of each treatment method were compared in terms of rate of complete resection, proce-
dure time, period of hospitalization, and complications. The tumor recurrence rates were compared between 30 
lesions in patients followed for 6 months or longer.
Results : On endoscopy, adenocarcinomas were either predominantly red or had patches of red significantly 
more often than did adenomas (P < 0.05). Erosion was seen significantly more frequently with adenocarcinoma 
than with adenoma (P < 0.05). Cancer-bearing rates were examined according to tumor diameter and macro-
scopic type. No cancer was observed in type 0-IIa or type 0-IIc lesions. The mean tumor diameter in which 
EMR was performed was 10.9 mm. The mean diameter of the tumors in which EPMR, ESD, HESD, or LECS 
was performed was ≥ 15 mm. Complete en bloc resection rates were 68.8% for EMR and 100% for HESD, ESD, 
and LECS.
Conclusion : The cancer-bearing rate of type 0-IIa lesions tended to be low and that of type 0-IIa + IIc or 
0-I with a tumor diameter of ≥ 15 mm tended to be high. This indicates that 10-15-mm elevated lesions can be 
resected completely by EMR. On the other hand, in the case of 10-15-mm recessed lesions suspected as cancer 
by preoperative endoscopy, ESD or HESD should be considered. Meanwhile, EPMR should be considered for 
type IIa lesions of ≥ 15 mm, whereas en bloc resection such as HESD, ESD, or surgical resection should be con-
sidered for type IIa + IIc lesions. Whether the lesion is cancerous and whether resection can be performed safely 
should be considered in selecting the therapeutic method.
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Introduction
Duodenal adenoma/adenocarcinoma is rare, and its 
prevalence rate remains to be established. The inci-
dence rate of primary duodenal cancer, however, is 
reported to be 0.035% for upper gastrointestinal cancer 
and from 33% to 45% for small intestinal cancer1).
With recent technological improvements in upper gas-
trointestinal endoscopy, the number of reported cases of 
duodenal tumors has gradually increased, and cases of 
endoscopic resection have been sporadically reported2-18). 
The number of accumulated cases of duodenal tumors, 
however, is not as large as that of of esophageal, gastric, 
or colonic cancers. Moreover, the endoscopic charac-
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teristics, invasion depth diagnosis, and therapeutic meth-
ods for duodenal tumors have not yet been established. 
Furthermore, endoscopic mucosal resection (EMR)5-7) 
and endoscopic submucosal dissection (ESD)8-11,14) are 
associated with an extremely high risk of perforation due 
to the thinness of the duodenal wall. The duodenum 
may also be more vulnerable to complications such as 
delayed bleeding or perforation than other parts of the 
gastrointestinal tract as it is exposed to bile and pancre-
atic juice. For these reasons, the duodenum is recog-
nized as the most difficult section of the gastrointestinal 
tract to treat by endoscopy. This may explain why few 
studies have reported on the efficacy and safety of endo-
scopic treatment of duodenal tumors.
Here, we report clinicopathological features and endo-
scopic treatment outcomes in primary superficial non-
ampullary duodenal epithelial tumors at our hospital.
Strategies for endoscopic treatment of duodenal 
tumors have not yet been established. We believe that 
the present results will offer useful information in decid-
ing treatment strategies for duodenal tumors.
Material and Methods
This study included 47 duodenal lesions (excluding 
papillary lesions) in 47 patients who underwent endo-
scopic treatment for duodenal tumors at Tokyo Medical 
University between April 2000 and September 2014. 
The clinicopathological features of the patients and 
tumors, including age, sex, tumor size, location, macro-
scopic type, and tumor color (red or not) were investi-
gated in relation to the histopathological diagnosis. 
Macroscopic duodenal tumors were classified using the 
criteria for colorectal tumors19). Short-term outcomes 
were evaluated in terms of rate of complete resection 
(CR), procedure time, period of hospitalization, and com-
plications. Bleeding was considered to have occurred if 
endoscopic hemostatic treatment, such as application of a 
clip or injection of a hemostatic agent, was required. 
Tumor recurrence rates between 30 lesions were com-
pared in patients followed for 6 months or longer. The 
first follow-up gastroscopy was performed 3 or 6 months 
after the initial resection in patients with tumors showing 
a histologically positive horizontal margin, and the sec-
ond follow-up gastroscopy after 1 year. All patients 
were informed of the risks and benefits of several treat-
ment options, including EMR, ESD, laparoscopic endo-
scopic collaboration surgery (LECS), and conventional 
surgery. Informed consent was obtained from all 
patients, and this research, was carried out in accordance 
with the Helsinki Declaration as revised in 2000. 
Endoscopic procedures
Hot biopsy procedure
This procedure involves using insulating forceps to 
collect tissue and destroy residual tumor by heat coagula-
tion, which also serves as the diagnosis and treatment. 
The polyp is grasped with the forceps and burned out by 
means of passing a high-frequency current through it. 
This process can easily be performed in a short time. 
This approach is best suited to a polyp of less than 5 mm 
in size.
EMR/EPMR procedures
Both EMR and endoscopic partial mucosal resection 
(EPMR) were performed by two endoscopists (T.G, 
M.F). The EMR was performed using a single-channel 
gastroduodenoscope (GIF Q260 and Q260J, Olympus 
Medical Systems, Tokyo, Japan). Saline containing a 
small amount of indigo carmine was used as the injection 
solution. A spiral snare, SnareMaster (Olympus Medi-
cal Systems) or Captivator II Snare (Boston Scientific 
Co., MA, USA) was used, and was selected in reference 
to the lesion size or particular situation. Any lesion that 
could not be resected in its entirety was resected piece-
meal. To control or prevent bleeding from visible ves-
sels within the artificial ulcer, bipolar electrocoagulation 
was performed immediately on completion of the proce-
dure. With piecemeal resection, all the pieces of the 
lesion were collected with net-type forceps. Conscious 
sedation was achieved by intravenous injection of mid-
azolam (2 mg) before insertion of the colonoscope. A 
further 2 mg was also given repeatedly in some cases 
according to the decision of the endoscopist. Cardiore-
spiratory function was monitored. Carbon dioxide 
(CO2) infusion was used instead of air infusion.
ESD/hybrid ESD procedures
Both ESD and hybrid ESD (HESD) were performed 
by two endoscopists (T.G, M.F). The same type of 
scope was used in both types of procedure. Before 
commencing resection, saline solution containing a small 
amount of indigo carmine was injected into the submu-
cosa near the tumor through needle forceps. Indigo car-
mine is added to submucosal injection fluid in order to 
achieve a more clearly identifiable blue-colored submu-
cosal layer. A monopolar knife is the most common 
choice at this institute (Dual Knife, IT knife-2, Olympus 
Medical Systems). The Dual Knife was used under the 
following settings : 30 W, effect 3, End-cut mode, and 
30 W, effect 3, Forced coagulation mode with ICC200. 
Carbon dioxide was used instead of air infusion. Mid-
azolam was administered intravenously for sedation as in 
the EMR/EPMR procedure. During ESD, a hard-type 
snare (20-mm spiral snare, Olympus Medical Systems) 
or a Captivator II Snare (Boston Scientific Co., MA, 
USA) was used if deemed necessary.
LECS procedure
The LECS procedure was performed under general 
anesthesia by a surgeon. A trocar was initially inserted 
at a site 12 mm to the left-lower abdominal site from the 
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middle/navel, followed by insertion of four more trocars. 
The affected mucosal and submucosal layers around the 
tumor were circumferentially dissected by using the ESD 
technique under intraluminal endoscopy. The lesion-
sited liminal wall was then artificially perforated. The 
tumor identified under laparoscopy was intra-abdomi-
nally inversed, and seromuscular dissection performed. 
The whole lesion was dissected circumferentially by 
using an ultrasonically activated device along the demar-
cation line. The perforated portion of the duodenum 
was closed by automatic machine anastomosis.
Statistical analysis
Statistical analyses were performed with SPSS Statis-
tics 22 (IBM Co. Ltd, Tokyo, Japan). Normally distributed 
data are presented as the mean ± standard deviation. The 
Student t-test was used to determine signifi cance ; a 
P-value of < 0.05 was considered to indicate a statisti-
cally significant difference. Univariate analysis was 
performed for each potential risk factor using the chi-
square test. In the second step, only significant factors 
on the chi-square analysis were included in a multivari-
ate (logistic regression) analysis.
Results
Patient characteristics and clinicopathologic features 
of lesions
The mean age of the patients was 58.8 years. There 
were more men (n = 32) than women (n = 15). The 
mean tumor diameter was 13.4 mm ± 7.5 mm. Lesions 
were localized in the bulb in 3 cases (6.4%), the second 
portion in 42 (89.4%) (proximal side of the papilla, 17 ; 
distal side of the papilla, 25), and the third portion in 2 
(4.2%). According to macroscopic type, 9 cases 
(19.1%) were type 0-I, 22 (46.8%) were type 0-IIa, 11 
(23.4%) were type IIa + IIc, and 5 (10.6%) were type 
IIc. There were 25 reddish lesions (53%) and 15 were 
accompanied by erosion. Hemorrhage and white villi 
were observed in 1 (2.1%) and 33 (70%) lesions, respec-
tively. Preoperative biopsy was carried out on 36 of a 
total of 47 duodenal lesions prior to primary endoscopic 
or surgical treatment. There were 39 cases (83%) of 
adenoma and 8 cases (17%) of adenocarcinoma (Table 
1). On endoscopy, adenocarcinomas were either pre-
dominantly red or had patches of red significantly more 
often than did adenomas (P < 0.05). Erosion was seen 
significantly more frequently with adenocarcinoma than 
with adenoma (P < 0.05) (Table 2).
When the cancer-bearing rates were investigated 
according to tumor diameter and macroscopic type, 2 of 
5 patients (40%) with type 0-I lesions and a tumor diam-
eter of ≥ 15 mm had cancer, whereas in cases with type 
0-IIa + IIc lesions, 2 (33%) had cancer, even when the 
tumor diameter was ≤ 15 mm. Thus, the cancer-bearing 
rate was higher when the tumor diameter was larger. In 
addition, no cancer was observed in type 0-IIa or type 
0-IIc lesions (Table 3).
Outcome of endoscopic procedures
The following therapeutic methods were used to treat 
the lesions : hot biopsy, 1 case (2.2%) ; EMR, 32 
(67%) ; EPMR, 9 (19%) ; HESD, 3 (4.4%) ; ESD, 1 
(2.2%) ; and LECS, 1 (2.2%). Tumors of macroscopic 
types 0-I and 0-IIc could be resected en bloc with the 
usual snare ; therefore, all were resected by EMR. 
However, flat tumors (type 0-IIa and 0-IIa + IIc) were 
treated with EPMR, HESD, or ESD, depending on the 
diameter of the tumor. Complete en bloc resection rates 
were 68.8% for EMR and 100% for HESD, ESD, and 
LECS. The mean procedure time was 15, 120, and 290 
minutes for EMR, ESD, and LECS, respectively. The 
duration of hospitalization after ESD or LECS was lon-
ger than that after EMR. Regarding adverse events, 
delayed bleeding was observed in 3 cases. Clip suture 
was performed in 39 patients (87%) ; however, of those, 
2 who experienced delayed bleeding had not received 
clip suturing. No perforation was observed during or 
after the procedure. Four patients underwent the proce-
dure under general anesthesia, and a pancreatic stent was 
placed preoperatively in 2 patients because the tumor and 
papilla were close to each other (Table 4).
Regarding the relationship between CR rate and tumor 
size/macroscopic type, the CR rate with elevated lesions 
such as type IIa or I when smaller than 15 mm was high, 
3
Table 1 Clinicopathological features
Total (n = 47)
Mean age (mean ± SD　year) 58.8 (± 19.8)
Sex  (M/F) 32/15
Tumor  size (mean ± SD　mm) 13.4 （± 7.5）
Location 
bulbs  3 (6.4%)
2nd 42 (85.1%)
3rd  2 (4.3%)
Macroscopic  type
I  9 (19.1%)
IIa 22 (46.8%)
IIa + IIc 11 (23.4%)
IIc  5 (10.6%)
Endoscopic findings
Redness 25 (53%)
Erosion 15 (31.9%)
Hemorrhage  1 (2.1%)
Whitened villi 33 (70%)
Preoperative biopsy 36 (76.6%)
Final histology
Tubular adenoma 34 (72.4%)
Tubulovillous adenoma  5 (10.6%)
adenocarcinoma  8 (17%)
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but with type IIa + IIc or type IIc lesions it was approxi-
mately 40%.
With a tumor diameter of more than 15 mm, the CR 
rate with type I lesions was high ; EPMR was performed 
for many type IIa lesions, whereas HESD or ESD was 
sometimes performed for IIa + IIc lesions (Table 5).
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Table 2 Relationship between endoscopic findings and final histological diagnosis
Adenoma (n = 39) Adenocarcinoma (n = 8) P-value
Tumor size (mean ± SD mm) 12.6 (± 7.7) 16.6 (± 5.7) N.S
Location 
bulbs  3 (7.7%)  0 N.S
2nd 34 (8.7%)  8 (100%) N.S
3rd  2 (5.1%)  0 N.S
Macroscopic type
I  7 (14.9%)  2 (4.3%) N.S
IIa 22 (46.8%)  0 (0%) N.S
IIa + IIc  5 (10.6%)  6 (12.8%) N.S
IIc  5 (10.6%)  0 (0%) N.S
Endoscopic findings
Redness 17 (43.6%)  7 (87.5%) P < 0.05
Erosion  7 (18%)  6 (75%) P < 0.05
Hemorrhage –  1 (12.5%) N.S
Whitened villi 18 (46.2%)  3 (37.5%) N.S
Table 3 Rate of carcinoma according to duodenal tumor macroscopic type
Macroscopic type ≤ 15 mm > 15 mm
0-I (n = 9)  0% (0/4) 40% (2/5)
0-IIa (n = 22)  0% (0/12)  0% (0/10)
0-IIa+IIc (n = 11) 33% (2/6) 80% (4/5)
0-IIc (n = 5)  0% (0/5) (−)
Total 2 (7.4%) 6 (30%)
Table 4 Short term of clinical outcome and results in resected specimens
Hot
(n = 1)
EMR ESD
LECS
(n = 1)EMR
(n = 32)
EPMR
(n = 9)
HESD
(n = 3)
ESD
(n = 1)
Macroscopic type
I 0  9  0  0  0  0
IIa 1 12  7  0  0  1
IIa+IIc 0  6  2  3  1  0
IIc 0  5  0  0  0  0
Tumor size (mean : mm) 3 10.9 19.4 17.5  20  25
Complete resection rate – 68.8% (22/32) – 100% (3/3) 100% (1/1) 100% (1/1)
Procedure time (mean : min) 8 15 36 48 120 290
Hospitalization (days) 3 5.3 6.6 7.2  15  16
Complications
Delayed bleeding 0  0 2 (22%) 1 (33%)  0  0
Perforation 0  0  0  0  0  0
Histology 
adenoma/M/SM 1 28/4/0 8/1/0 1/2/0 0/0/1 1/0/0
lymphovascular invasion – – –
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Case report
A 75-year-old man presented with a 1-week history of 
epigastralgia. Endoscopy revealed a 20-mm type IIa + 
IIc lesion in the second portion, opposite to the papilla. 
Because the lesion was large and included a depression, 
ESD was performed. The lesion was completely 
removed en block.
The size of the resected tumor was 15 × 14 mm, and 
histopathologic examination revealed well differentiated 
tubular adenocarcinoma with submucosal (SM) invasion 
of 300 μm (Figure 1, 2).
Follow-up outcome
The mean follow-up period was 24.3 months. Resid-
ual/local recurrence was observed in 2 patients. One of 
these patients had a 3-mm type IIa lesion in the second 
portion of the duodenum and was first treated by hot 
biopsy. A 2-mm residual lesion observed on examina-
tion 6 months after this procedure was also treated with 
hot biopsy. Histopathological examination revealed that 
the lesion was an adenoma. The other patient had a 
15-mm type IIa + IIc lesion in the second portion of the 
duodenum, and hot biopsy was additionally performed 
for a minimal residual lesion after EMR. Histopatho-
logical examination revealed that the lesion was an 
intramucosal adenocarcinoma. Because the resection 
margin was unclear, however, reexamination was per-
formed 3 months later. A 5-mm-diameter elevated 
lesion was observed at the scar of the procedure ; there-
fore, hot biopsy was performed. Histopathological 
examination revealed that the tumor was an adenocarci-
noma. No residual tumor or recurrence has been 
observed on follow-up endoscopy in either of the lesions 
(Table 6).
Discussion
Cases of primary non-ampullary duodenal tumors are 
rare, and fewer have been reported than those of esopha-
geal, gastric, or colonic tumors. Therefore, the clinico-
pathological features of this type of tumor and the stan-
dard therapeutic approach remain to be established. In 
this study, we investigated clinicopathological features 
and endoscopic treatment outcomes in primary non-
ampullary duodenal tumors. Endoscopic findings 
revealed that adenocarcinoma was more likely to present 
with redness than adenoma. When cancer-bearing rates 
were compared according to macroscopic type or tumor 
diameter, the cancer-bearing rate of type 0-IIa lesions 
tended to be low and that of type 0-IIa + IIc or 0-I with a 
tumor diameter of ≥15 mm tended to be high. In addi-
tion, the cancer-bearing rate increased with increase in 
tumor diameter.
Endoscopy is indicated for neoplastic lesions with no 
potential lymph node metastasis. In a study of 128 
patients with early duodenal cancer, Nagatani et al. 
reported that lymph node metastasis was not observed in 
patients with mucosal (M)-cancer, but that lymph node 
metastasis was observed in ≥ 5% of the patients with 
SM-cancer2). In a study of 396 patients, Goda et al. 
reported that lesions with a tumor diameter of ≥ 6 mm 
and redness on the surface were very likely to be high-
grade adenoma/adenocarcinoma ; all cases of SM-inva-
sive carcinoma presented with redness ; and the macro-
scopic type was either 0-I or 0-IIa + IIc16). Kakushima 
et al. reported that 11 of 13 lesions diagnosed as high-
grade adenoma by biopsy were finally revealed to be 
adenocarcinoma according to histopathological examina-
tion of the resected specimen20). These findings suggest 
that if an untreated tumor is ≥ 5 mm in diameter and is 
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Table 5 Relationship between CR rate and tumor size /macroscopic type
≤ 15 mm > 15 mm
hot
(n = 1)
EMR EMR ESD
LECS
(n = 1)EMR
(n = 25)
EPMR
(n = 1)
EMR
(n = 7)
EPMR
(n = 8)
HESD
(n = 3)
ESD
(n = 1)
I – 4 
(CR : 100%)
– 5 
(CR : 100%)
– – – –
IIa 1 
(CR : 0%)
11
(CR : 82%)
– 1 
(CR : 0%)
7 
(CR : 0%)
1 
(CR : 100%)
– 1 
(CR : 100%)
IIa + IIc – 5 
(CR : 40%)
1 
(CR : 0%)
1 
(CR : 0%)
1 
(CR : 0%)
2 
(CR : 100%)
1 
(CR : 100%)
–
IIc – 5 
(CR : 40%)
– – – – – –
CR rate 0% 68% (17/25) 0% 71% (5/7) 0% 100% (3/3) 100% (1/1) 100% (1/1)
  CR : complete resection
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histologically diagnosed as high-grade adenoma, it can 
be treated. The present results also suggest that the 
cancer-bearing rates of types 0-IIa + IIc and 0-I tumors 
are high, so this type of tumor may be SM-invasive and 
should be resected en bloc.
Preoperative biopsy was carried out in 36 of a total 47 
duodenal lesions prior to primary treatment at our hospi-
tal. Only one original diagnosis of low-grade adenoma 
6
Fig. 1 Endoscopic view of duodenal tumor
 Male patient aged 75 yr ; 2nd portion (opposite papilla), 20 mm, 0-IIa + IIc
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based on a preoperative biopsy was changed to carci-
noma according to a final histological analysis. The 
accuracy of preoperative diagnosis by biopsy for ade-
noma or carcinoma was 94%. Preoperative biopsy is 
very useful in achieving a definitive diagnosis. How-
ever, actually, the lesion was accompanied by severe 
fibrosis in the submucosal layer and did not show large 
elevation, even with glycerin injection, probably due to 
many biopsies prior to treatment. We tried EMR for 
one IIa + IIc 10-mm lesion accompanied by severe fibro-
sis according to the results of several biopsies. There 
was no sign of elevation, however, and finally the lesion 
was treated by EPMR. When endoscopic resection is 
being considered for a lesion, especially if it is flat or 
depressed, it is necessary to assess the degree of neoplas-
tic atypism by endoscopic means rather than relying on a 
biopsy, as a biopsy may cause fibrosis. Thus, preopera-
tive biopsy should be avoided.
Standard strategies for the endoscopic treatment of 
duodenal tumors remain to be established. Handling 
the endoscope is often difficult due to the anatomical 
characteristics of the duodenum, such as the thin wall 
and narrow lumen. Therefore, the incidence rate of 
adverse events during and after the procedure is higher in 
Fig. 2 Pathological diagnosis
 Well-differentiated tubular adenocarcinoma (tub1)
 (15 × 14 mm, 0-IIa + IIc, pSM (300 μm), v0, ly0, HM0, 
VMO)
Table 6 Residual/Recurrent lesions 
EMR (n = 1) Hot (n = 1)
Macroscopic type  IIa + IIc IIa
Tumor size prior to treatment (mm) 15 3
Tumor size of residual/recurrent lesion (mm) 5 2
 Additional treatment Hot biopsy Hot biopsy
Time of additional treatment 1 1
Histology adenocarcinoma adenoma
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the duodenum than in other digestive tracts ; thus, extra 
caution should be exercised when selecting a treatment 
method. In the present study, the mean tumor diameter 
in which EMR was performed was 10.9 mm. 
When performed on type I or type IIa lesions smaller 
than 15 mm, EMR yielded a high CR rate, but when 
applied in type IIa + IIc or type IIc lesions the CR rate 
was low. This suggests that 10-15-mm elevated lesions 
can be resected completely by EMR. On the other 
hand, in the case of 10-15-mm recessed lesions sus-
pected as cancer by preoperative endoscopy, ESD or 
HESD should be considered, although the latter offers 
the best option as it requires less time to perform than the 
former. The mean diameter of the tumors in which 
EPMR, ESD, HESD, or LECS was performed was large 
(≥ 15 mm). Most (77.8%) of the lesions in which 
EPMR was performed were type IIa, and no local recur-
rence was observed during the follow-up observation. 
Regarding HESD and ESD, en bloc resection is possible, 
even in large tumors. At our hospital, 75% of tumors in 
which HESD or ESD was performed were type IIa + IIc. 
Histopathologically, the cancer-bearing rate of type IIa 
lesions is low, whereas that of type IIa + IIc lesions is 
high. Therefore, EPMR should be considered for type 
IIa lesions of 15 mm, whereas en bloc resection such as 
HESD or ESD should be considered for type IIa + IIc 
lesions. However, in the case of HESD and ESD, the 
procedure time and duration of hospitalization tended to 
be long, although the rate of en bloc resection was high. 
Although no differences were observed in adverse events 
at our hospital, this may have been because the number 
of cases was small. Honda et al. reported that delayed 
perforation occurred in 2 (22%) of 9 patients who under-
went ESD for a duodenal tumor9). Takahashi et al.10), 
Endo et al.12), and Jung et al.13), reported intraoperative 
perforation in 50% (2/4), 20% (1/5), and 35.7% (5/14) of 
patients, respectively. Furthermore, Inoue et al.21) endo-
scopically resected duodenal tumors in 63 patients and 
reported postoperative delayed perforation in 6.3%. In 
all of these cases, EPMR or ESD had been performed on 
the distal side of the papilla, indicating that delayed per-
foration was associated with tumor site or resection 
method. As for measures against postoperative adverse 
events, many studies have reported that clip suture is 
effective in the treatment of postoperative ulcers17)22). In 
the present study, 3 patients (66%) had secondary hemor-
rhage as an adverse event, of whom 2 had not received 
clip suturing. Recent studies have shown that endo-
scopic ulcers can be prevented by shielding of mucosal 
defects with polyglycolic acid sheets and fibrin glue23-25), 
and suturing is performed using an Over-The-Scope Clip 
system26). These procedures are expected to be widely 
used in the future.
In the present study, the patient in whom LECS was 
performed had a 25-mm type IIa lesion in the superior 
duodenal angle. We chose LECS here as handling the 
endoscope was difficult and the lesion was on the oppo-
site side of the papilla (Fig. 1-2). This procedure is less 
invasive than laparoscopic surgery alone and it also 
allows firmer suturing of the resected surface than endo-
scopic resection. Thus, it has merit in reducing the risk 
of postoperative complications. However, the sites at 
which it can be applied are limited : it cannot be applied 
when the lesion is on the duodenal papilla side or when 
the size of the lesion is larger than one-third of the cir-
cumference of the duodenum. It also carries the risk of 
intraperitoneal exposure, a problem that needs to be 
addressed27).
Regarding residual and recurrent lesions, small, possi-
bly residual lesions were observed in patients who under-
went hot biopsy and EMR. Additional endoscopic 
treatment was performed in all of these patients. To 
date, no recurrence has been observed, and the patients 
are still being followed. Only a few studies have 
focused on long-term results after endoscopic treatment. 
Nonaka et al. reported long-term outcomes in 121 
patients with duodenal tumor treated with endoscopic 
surgery (en bloc resection, 77 patients ; piecemeal resec-
tion, 43 patients) and found that none had local failure 
such as recurrence of invasive cancer, suggesting that 
EMR, including piecemeal resection, can be indicated for 
duodenal tumors17).
The aforementioned findings suggest that endoscopic 
treatment of primary non-ampullary duodenal tumors is 
much more effective than surgical resection. Although 
further study is needed to establish standard therapeutic 
methods for duodenal tumors, we believe that not all 
lesions need to be resected en bloc ; instead, piecemeal 
resection of lesions, if clinicopathologically possible, 
may be required to prevent the occurrence of adverse 
events.
The present study had several limitations. It was per-
formed at a single center by 2 skilled endoscopists with a 
relatively small number of patients, and there was no 
control group.
In conclusion, the treatment outcomes described here 
suggest that while en block resection is preferable in type 
0-I or IIa + IIc lesions in the case of non-ampullary duo-
denal tumors, piecemeal resection can be indicated in 
type IIa lesions. Selection of ESD, HESD, or surgical 
resection should depend on tumor diameter, lesion site, 
or maneuverability of the endoscope. Whether a lesion 
is cancerous and whether resection can be performed 
safely should be considered in selecting the therapeutic 
approach.
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非乳頭部十二指腸腫瘍に対する内視鏡治療成績
竹　内　眞　美　　　福　澤　誠　克　　　河　合　　　隆 
森　安　史　典
東京医科大学消化器内科
【要旨】　背景 : 非乳頭部原発性十二指腸腫瘍はまれな病変疾患である。そのため十分な症例集積がなされておらず
その内視鏡像の特徴・深達度診断・治療法は確立されていない。今回我々は当院で経験した非乳頭部原発性十二指
腸腫瘍 47例の臨床病理学的特徴およびその内視鏡治療成績について検討した。  
　方法 : 内視鏡切除が施行された十二指腸腫瘍 47例を対象とし、年齢・性別・腫瘍径・占居部位・色調・肉眼型・
組織型・（肉眼型 /）腫瘍径別の担癌率などの臨床病理学的特徴および治療法別の腫瘍径・占居部位・肉眼型・短期
治療成績（組織型・深達度・脈管浸襲・一括切除率・偶発症）について検討した。さらに、6ヶ月以上経過観察が
可能だった 30病変を対象として遺残再発率を検討した。  
　結果 : 内視鏡所見では腺腫と腺癌を比較した場合、発赤・びらんを認めるものが有意に癌で多かった（P < 0.05）。
肉眼型と腫瘍径による担癌率の比較では、0-IIa+IIc型において 15 mm未満 : 33%，15 mm以上 : 80%，0-I型 
15 mm以上 : 40%の担癌率を認めた。一方 0-IIa型、0-IIcの担癌率は 0%であった。治療法別の平均腫瘍径をみる
と EMRは 10.9 mm、EPMR、ESD、Hybrid ESD （HESD）、LECSを行った腫瘍の平均腫瘍型は全て 15 mm以上と大
きかった。一括切除率は EMRでは 68.8%、HESD、ESD、LECSでは 100%であった。  
　結論 : 0-IIa型の担癌率は低く、0-IIa+IIc型，15 mm以上の 0-I型において担癌率が高い傾向がみられた。10-
15 mmの隆起性病変に関しては EMRで対応可能と考えられるが、癌を疑う陥凹を伴う病変は ESDもしくは ESDよ
り短時間での処置が可能な HESDを検討すべきである。15 mm以上の IIa病変は EPMR、IIa+IIc病変は一括切除を
めざすべき病変と考えられた。その病変の肉眼型、担癌率および技術的な安全性を十分考慮し治療法を選択してい
くことが重要である。
〈キーワード〉十二指腸腫瘍、内視鏡切除、治療成績
